Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Quantum Biopharma ( (TSE:QNTM) ) just unveiled an update.
Quantum BioPharma Ltd., a company listed on NASDAQ, CSE, and FRA, has announced the closing of a third tranche of its offering, issuing 1,480 Debenture Units for $1,480,000. The company has amended the terms of these units due to a decrease in the market price of its Class B shares, adjusting the conversion price, increasing warrants per unit, and securing obligations against company property. Proceeds from this transaction will support the development of the company’s business model and general working capital.
More about Quantum Biopharma
YTD Price Performance: -16.18%
Average Trading Volume: 132,382
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $6.51M
See more data about QNTM stock on TipRanks’ Stock Analysis page.
